06185 康希諾生物
按盤價 
18.820 +0.460 (+2.505%) | 2023/12 - 末期 人民幣() | 2022/12 人民幣() | 2021/12 人民幣() | 2020/12 人民幣() | 2019/12 人民幣() | |
| 經營活動之現金流量 | (916,252,000) | (1,887,599,000) | 2,014,557,000 | (469,389,000) | (170,189,000) |
| 投資活動之現金流量 | (441,622,000) | (1,191,955,000) | (2,531,270,000) | (182,713,000) | (797,770,000) |
| 融資活動之現金流量 | (7,582,000) | 854,602,000 | 1,559,922,000 | 4,923,518,000 | 1,090,826,000 |
| 現金及等同現金之增加/(減少) | (1,365,456,000) | (2,224,952,000) | 1,043,209,000 | 4,271,416,000 | 122,867,000 |
| 期初之現金及現金等價物 | 3,391,268,000 | 5,455,456,000 | 4,446,029,000 | 201,973,000 | 57,381,000 |
| 匯率變動之影響 | 20,287,000 | 160,764,000 | (33,782,000) | (27,360,000) | 21,725,000 |
| 其他 | 0 | 0 | 0 | 0 | 0 |
| 期末之現金及現金等價物 | 2,046,099,000 | 3,391,268,000 | 5,455,456,000 | 4,446,029,000 | 201,973,000 |
| 備註： | 即時報價更新時間為26/04/2024 18:00 |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
| 股東應佔溢利/(虧損) () | RMB -1,482,732,000 |
| 增長率 | 63.040% |
| 每股盈利/(虧損) | RMB -6.010 |
| 每股帳面資產淨值 (¥) | RMB 21.316 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
